ArriVent BioPharma
AVBP
#7246
Rank
โ‚ฌ0.49 B
Marketcap
9,59ย โ‚ฌ
Share price
-6.57%
Change (1 day)
-45.73%
Change (1 year)

ArriVent BioPharma (AVBP) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : โ‚ฌ25.41 Million

According to ArriVent BioPharma's latest financial reports the company's total liabilities are โ‚ฌ25.41 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

ArriVent BioPharma - Total liabilities on balance sheet (from 2022 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31โ‚ฌ22.08 M32.94%
2024-12-31โ‚ฌ16.61 M-94.19%
2023-12-31โ‚ฌ0.28 B14.54%
2022-12-31โ‚ฌ0.24 B15460.32%
2021-12-31โ‚ฌ1.6 M